ArticleJAMA neurology2017

Induction of New Autoimmune Diseases After Alemtuzumab Therapy for Multiple Sclerosis: Learning From Adversity.

Lawrence SteinmanPubMed ↗Publisher ↗

No numbers read from the abstract.